<HTML>
<HEAD>
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>FORM 8-K</TITLE>
</HEAD>
<BODY LINK="#0000ff">

<FONT FACE="CG Times,Times New Roman">
<P>&nbsp;</P>
<B><P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
</B><P ALIGN="CENTER">Washington, D.C.  20549</P>
<P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">FORM 8-K</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">CURRENT REPORT</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Date of Report (Date of earliest event reported): February 24, 2003</P>

<P>&nbsp;</P>
<P>&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mediware Information Systems, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U></FONT><FONT FACE="CG Times,Times New Roman" SIZE=2>(Exact name of registrant as specified in its charter)</P>
</FONT><FONT FACE="CG Times,Times New Roman">
<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD VALIGN="TOP" COLSPAN=4>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1-10768&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11-2209324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Commission File Number)</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=2><P ALIGN="CENTER">(IRS Employer<BR>
Identification No.)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11711 West 79th Street, Lenexa, KS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="63%" VALIGN="TOP" COLSPAN=3>
<FONT SIZE=2><P ALIGN="CENTER">(Address of principal executive offices)</FONT></TD>
<TD WIDTH="37%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Zip Code)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">Registrant's telephone number, including area code<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(913) 307-1000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</U></FONT><FONT SIZE=2><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
<P ALIGN="CENTER">______________________________________________________________________________</P>

<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>Item 5.&nbsp;&nbsp;<U>Other Events and Regulation FD Disclosure.</P>
</U>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February 24, 2003 Mediware Information Systems, Inc. (the "Company") issued a press release (the &quot;Release&quot;) announcing that it had received U.S. Food and Drug Administration 510(k) clearance for the Company's Hemocare LifeLine transfusion management system.  A copy of the Release is attached as an Exhibit hereto.</P>

<P>Item 7.&nbsp;&nbsp;<U>Financial Statements and Exhibits.</P>
</U><DIR>
<DIR>

<P>(c)(1) Press Release issued by the Company on February 24, 2003.</P>

<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P></DIR>
</DIR>

<B><P ALIGN="CENTER">SIGNATURES</P>
</B>
<P>&nbsp;</P>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=615>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>MEDIWARE INFORMATION SYSTEMS, INC</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Date:&#9;February 24, 2003</FONT></TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>By:&nbsp;&nbsp;<U>/s/ George J. Barry<BR>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;George J. Barry<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman">
<P>&nbsp;</P>
<P>&nbsp;</P>
<B><U><P>&nbsp;</P>
<P>&nbsp;</P>
</U><P ALIGN="CENTER">EXHIBIT INDEX</P>

<P><BR>
</P>
</B><P ALIGN="CENTER">Exhibit (c)(1) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release issued by the Company on February 24, 2003.</P>
<P ALIGN="CENTER"></P>
<B><P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="RIGHT">&nbsp;</P><DIR>
<DIR>
<DIR>

</FONT><FONT FACE="CG Times,Times New Roman" SIZE=4><P ALIGN="RIGHT">Exhibit</FONT><FONT FACE="CG Times,Times New Roman"> (c)(1)</P>

<P>&nbsp;</P>
</FONT><I><FONT SIZE=1><P>&nbsp;</P></DIR>
</DIR>
</DIR>
</B></I></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=513>
<TR><TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Contacts</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>George Barry<BR>
913/307-1000<BR>
www.mediware.com</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Thomas Redington<BR>
203/222-7399<BR>
212/926-1733<BR>
www.redingtoninc.com</B></U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<B>
<P>&nbsp;</P>
<P ALIGN="CENTER">Mediware Information Systems, Inc. Receives FDA 510(k) Clearance<BR>
</B><U>For&nbsp;&nbsp;&nbsp;&nbsp;its&nbsp;&nbsp;&nbsp;&nbsp;Next-Generation&nbsp;&nbsp;&nbsp;&nbsp;Transfusion&nbsp;&nbsp;&nbsp;&nbsp;Management&nbsp;&nbsp;&nbsp;&nbsp;System</P>
</U><DIR>
<DIR>
<DIR>

<B><P ALIGN="JUSTIFY">LENEXA, KS&nbsp;&nbsp;&nbsp;Feb. 24&nbsp;&nbsp;</B>- Mediware Information Systems, Inc. (Nasdaq: MEDW), a known leader in healthcare delivery and patient safety software management solutions, announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its next-generation transfusion management system, Hemocare LifeLine (HCLL&trade;), in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act.</P>
<P ALIGN="JUSTIFY">The HCLL next-generation transfusion management system is designed to manage blood products administered to patients at hospitals and centralized transfusion service facilities.  HCLL greatly expands on the functions and features offered by traditional legacy transfusion systems while supporting the main objective of enhancing patient safety within complex hospital environments.  Enhanced management features and functions of HCLL include:</P></DIR>
</DIR>
</DIR>


<UL><DIR>
<DIR>


<UL>
<P ALIGN="JUSTIFY"><LI>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advanced capabilities for centralized transfusion services, electronic and remote cross-matching, and quality control management; </LI></P>
<P ALIGN="JUSTIFY"><LI>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ability to scale transfusion services for a single hospital as well as for large multi-site/multi-facility hospital networks; complete integration with hospital and laboratory information systems; configurations in Client/Server or Thin-Client Web-enabled platforms; and full support of industry bar code standards and  enhanced process flow and control.</LI></P></UL>
</DIR>
</DIR>
</UL>

<P ALIGN="JUSTIFY"></P><DIR>
<DIR>
<DIR>

<P ALIGN="JUSTIFY">Commenting on the FDA 510(k) clearance, George Barry, Mediware's CEO said, &quot;The company has expended tremendous clinical and technical effort over the last four years to ensure HCLL supports the overall objective of enhancing patient safety, along with incorporating advanced technical capabilities that make a significant operational impact on our clients' transfusion services." </P>
<FONT SIZE=3><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<B><P ALIGN="JUSTIFY">About Mediware Information Systems, Inc.</P>
</B><P ALIGN="JUSTIFY">Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include Hemocare&trade;, LifeLine&trade; and LifeTrak&trade; (blood bank), WORx&trade;, Pharmakon&reg;, and Digimedics&trade; (pharmacy), Surgiware&trade;, Perioperative Solutions&trade; (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
</FONT><I><FONT FACE="CG Times,Times New Roman"><P ALIGN="JUSTIFY">Certain statements in this press release may constitute "forward- ooking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2002, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements. </P>
</I></FONT><FONT SIZE=3><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">2/24/03</P>
</FONT></DIR>
</DIR>
</DIR>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8k2-03.htm", "secsgml_size_bytes": 10726}]
{"company-data": {"conformed-name": "MEDIWARE INFORMATION SYSTEMS INC", "cik": "0000874733", "assigned-sic": "7373", "irs-number": "112209324", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10768", "film-number": "03578193"}, "business-address": {"street1": "11711 W 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "11747", "phone": "5164237800"}, "mail-address": {"street1": "1121 OLD WALT WHITMAN RD", "city": "MELVILLE", "state": "NY", "zip": "11747-3005"}}
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2003
Mediware Information Systems, Inc.
(Exact name of registrant as specified in its charter)
New York                                 1-10768                                 11-2209324
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
11711 West 79th Street, Lenexa, KS                                            66214
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code
(913) 307-1000
______________________________________________________________________________
Item 5.
Other Events and Regulation FD Disclosure.
On February 24, 2003 Mediware Information Systems, Inc. (the "Company") issued a press release (the "Release") announcing that it had received U.S. Food and Drug Administration 510(k) clearance for the Company's Hemocare LifeLine transfusion management system.  A copy of the Release is attached as an Exhibit hereto.
Item 7.
Financial Statements and Exhibits.
(c)(1) Press Release issued by the Company on February 24, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDIWARE INFORMATION SYSTEMS, INC
Date:	February 24, 2003
By:
/s/ George J. Barry
George J. Barry
Chief Executive Officer
EXHIBIT INDEX
Exhibit (c)(1)       Press Release issued by the Company on February 24, 2003.
Exhibit
(c)(1)
Contacts
George Barry
913/307-1000
www.mediware.com
Thomas Redington
203/222-7399
212/926-1733
www.redingtoninc.com
Mediware Information Systems, Inc. Receives FDA 510(k) Clearance
For    its    Next-Generation    Transfusion    Management    System
LENEXA, KS   Feb. 24
- Mediware Information Systems, Inc. (Nasdaq: MEDW), a known leader in healthcare delivery and patient safety software management solutions, announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its next-generation transfusion management system, Hemocare LifeLine (HCLL™), in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act.
The HCLL next-generation transfusion management system is designed to manage blood products administered to patients at hospitals and centralized transfusion service facilities.  HCLL greatly expands on the functions and features offered by traditional legacy transfusion systems while supporting the main objective of enhancing patient safety within complex hospital environments.  Enhanced management features and functions of HCLL include:
Advanced capabilities for centralized transfusion services, electronic and remote cross-matching, and quality control management;
Ability to scale transfusion services for a single hospital as well as for large multi-site/multi-facility hospital networks; complete integration with hospital and laboratory information systems; configurations in Client/Server or Thin-Client Web-enabled platforms; and full support of industry bar code standards and  enhanced process flow and control.
Commenting on the FDA 510(k) clearance, George Barry, Mediware's CEO said, "The company has expended tremendous clinical and technical effort over the last four years to ensure HCLL supports the overall objective of enhancing patient safety, along with incorporating advanced technical capabilities that make a significant operational impact on our clients' transfusion services."
About Mediware Information Systems, Inc.
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include Hemocare™, LifeLine™ and LifeTrak™ (blood bank), WORx™, Pharmakon®, and Digimedics™ (pharmacy), Surgiware™, Perioperative Solutions™ (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.
#       #	       #
Certain statements in this press release may constitute "forward- ooking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2002, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
2/24/03